-
公开(公告)号:US07273929B2
公开(公告)日:2007-09-25
申请号:US10443349
申请日:2003-05-22
CPC分类号: C07K14/47 , A01K2217/05 , A61K38/00 , C07K14/78
摘要: Recombinant laminin B1k and fragments thereof.
摘要翻译: 重组层粘连蛋白B1k及其片段。
-
公开(公告)号:US5914317A
公开(公告)日:1999-06-22
申请号:US735893
申请日:1996-10-23
IPC分类号: A01K67/027 , A61K38/00 , C07K7/08 , C07K14/47 , C07K14/78 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/68 , C07K14/00 , A61K38/39
CPC分类号: C07K14/47 , C07K14/78 , A01K2217/05 , A61K38/00
摘要: Recombinant laminin B1k and fragments thereof.
摘要翻译: 重组层粘连蛋白B1k及其片段。
-
公开(公告)号:US06916631B2
公开(公告)日:2005-07-12
申请号:US10841139
申请日:2004-05-07
IPC分类号: A01K67/027 , A61K38/00 , C07K7/08 , C07K14/47 , C07K14/78 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/68 , G12P21/06 , A07K16/28 , A62K39/395
CPC分类号: C07K14/47 , A01K2217/05 , A61K38/00 , C07K14/78
摘要: Antibodies directed against laminin B1k are provided.
摘要翻译: 提供了针对层粘连蛋白B1k的抗体。
-
公开(公告)号:US06693169B1
公开(公告)日:2004-02-17
申请号:US09415625
申请日:1999-10-12
IPC分类号: C07K1478
CPC分类号: C07K14/78
摘要: The present invention features two members of laminin family, i.e., laminin 13 and laminin 14, the methods of making these molecules, and the methods of using these molecules in treating neural disorders, e.g., retinal disorders. The present invention also features using a preparation of laminin 5 to treat neural disorders, especially disorders associated with retina.
摘要翻译: 本发明具有层粘连蛋白家族的两个成员,即层粘连蛋白13和层粘连蛋白14,制备这些分子的方法,以及使用这些分子治疗神经障碍如视网膜疾病的方法。 本发明还特征在于使用层粘连蛋白5的制剂来治疗神经障碍,特别是与视网膜相关的疾病。
-
公开(公告)号:US06682911B1
公开(公告)日:2004-01-27
申请号:US09561709
申请日:2000-05-01
IPC分类号: C12P2102
CPC分类号: C07K14/78
摘要: The present invention is based on the discovery of a novel member of the laminin family, laminin 12. Accordingly, the present invention features a purified or isolated preparation or a recombinant preparation of laminin 12 which includes an &agr;2 subunit, &bgr;1 subunit and a &ggr;3 subunit.
摘要翻译: 本发明是基于层粘连蛋白家族层叠蛋白12的新成员的发现。因此,本发明的特征在于一种纯化或分离的制剂或层粘连蛋白12的重组制剂,其包括α2亚基,β1亚基和γ3亚基 。
-
6.
公开(公告)号:US5770562A
公开(公告)日:1998-06-23
申请号:US469500
申请日:1995-06-06
申请人: Robert E. Burgeson , Gregory P. Lunstrum , Patricia Rousselle , Douglas R. Keene , M. Peter Marinkovich
发明人: Robert E. Burgeson , Gregory P. Lunstrum , Patricia Rousselle , Douglas R. Keene , M. Peter Marinkovich
CPC分类号: C12N5/0629 , A61K38/39 , A61L27/227 , A61L27/60 , C12N5/0068 , C12N2501/58 , C12N2533/50 , C12N2533/52 , Y10S530/842
摘要: The isolated proteins kalinin and k-laminin are disclosed to provide adhesion between epidermal keratinocytes and the underlying dermis. Purified kalinin localizes to the anchoring filaments of basement membranes of human subepithelial skin, trachea, esophagus, cornea and amnion when such areas are probed with BM165 monoclonal antibody after localization. The protein has a molecular weight of approximately 410-495 kDa and exists in a cell-associated form (about 495 kDa) and two medium-associated forms (about 460 and 410 kDa, respectively). The BM165 epitope is located on the 165-kDa and 200 kDa subunits. Kalinin has a rotary-shadow image revealing an asymmetric rod 107-nm long having two globules at a first end and a single globule at an opposing end. The k-laminin adhesion molecule is an isolated heterotrimeric laminin variant that has a molecular weight of about 650 kDa and separates on western blots into first and second fragments that are similar to the B1 and B2 fragments of laminin. K-laminin also includes a third fragment of 190 kDa that is not immunoreactive with monoclonal antibodies 1F5, 11D5 and 4C7, but is immunoreactive with a monoclonal antibody BM165. Kalinin and k-laminin are preferably covalently associated. A method is also disclosed for improving adhesion of transplanted keratinocytes to an underlying substrate, such as the human dermis, by optimizing production of kalinin from cultured keratinocytes, or by providing an exogenous source of kalinin between the keratinocytes and substrate.
摘要翻译: 公开了分离的蛋白质kalinin和k-层粘连蛋白以提供表皮角化细胞和潜在的真皮之间的粘附。 纯化的卡林林定位于人类上皮皮肤,气管,食管,角膜和羊膜的基底膜的锚定细丝上,当这些区域在定位后用BM165单克隆抗体探测时。 蛋白质具有约410-495kDa的分子量,并以细胞相关形式(约495kDa)和两种培养基相关形式(分别为约460和410kDa)存在。 BM165表位位于165kDa和200kDa亚基上。 加里宁具有旋转阴影图像,其显示107nm长的不对称杆,在第一端具有两个球,在相对端具有单个球。 k-层粘连蛋白粘附分子是分离的异三聚体层粘连蛋白变体,其分子量为约650kDa,并将蛋白质印迹分离成与层粘连蛋白的B1和B2片段相似的第一和第二片段。 K-层粘连蛋白还包括与单克隆抗体1F5,11D5和4C7不具有免疫反应性的190kDa的第三片段,但是与单克隆抗体BM165具有免疫反应性。 卡利宁和k-层粘连蛋白优选共价结合。 还公开了通过优化来自培养的角质形成细胞的生产kalinin或通过在角质形成细胞和底物之间提供外源的卡林林来改善移植的角质形成细胞与底物(例如人真皮)的粘附的方法。
-
公开(公告)号:US5610031A
公开(公告)日:1997-03-11
申请号:US144121
申请日:1993-10-27
IPC分类号: A01K67/027 , A61K38/00 , C07K7/08 , C07K14/47 , C07K14/78 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/68 , C12N15/11 , C12N15/12
CPC分类号: C07K14/47 , C07K14/78 , A01K2217/05 , A61K38/00
摘要: Recombinant laminin B1k and fragments thereof.
摘要翻译: 重组层粘连蛋白B1k及其片段。
-
公开(公告)号:US6153593A
公开(公告)日:2000-11-28
申请号:US868600
申请日:1997-06-04
申请人: Robert E. Burgeson , Makoto Tsunenaga , Satoshi Amano , Toshio Nishiyama , Eijiro Adachi , Nobuyuji Shioya
发明人: Robert E. Burgeson , Makoto Tsunenaga , Satoshi Amano , Toshio Nishiyama , Eijiro Adachi , Nobuyuji Shioya
IPC分类号: C12N15/09 , A61K38/00 , A61K38/39 , A61L27/22 , A61L27/38 , A61L27/60 , C12N5/00 , C12N5/071 , A01N1/02 , A61F2/10 , C12N5/08
CPC分类号: C12N5/0629 , A61K38/39 , A61L27/227 , A61L27/3813 , A61L27/60 , C12N5/0068 , C12N2501/58 , C12N2533/52 , Y10S623/901
摘要: The use of laminin-5 to promote formation of basement membrane and to form skin equivalents and to improve grafting of keratinocyte sheets.
摘要翻译: 使用层粘连蛋白-5促进基底膜的形成并形成皮肤等同物并改善角质形成细胞片的接枝。
-
9.
公开(公告)号:US6133236A
公开(公告)日:2000-10-17
申请号:US815886
申请日:1997-03-12
申请人: Robert E. Burgeson , Gregory P. Lunstrum , Patricia Rouselle , Douglas R. Keene , M. Peter Marinkovich
发明人: Robert E. Burgeson , Gregory P. Lunstrum , Patricia Rouselle , Douglas R. Keene , M. Peter Marinkovich
CPC分类号: A61K38/39 , A61L24/108 , A61L27/227 , A61L27/60 , C12N2501/58 , C12N2533/50 , C12N2533/52
摘要: Improving adhesion of epidermis to an underlying dermal substrate including the step of providing an amount of purified kalinin between the epidermis and dermal substrate wherein the kalinin provides adhesion between the human dermis and epidermis wherein said kalinin is a trimeric molecule having the following three nonidentical chains: a chain which includes the BM165 epitope, either a 155 kilodalton chain or a 105 kilodalton chain, and a 140 kilodalton chain.
摘要翻译: 改善表皮与潜在皮肤基质的粘附,包括在表皮和皮肤底物之间提供一定量的纯化的卡林林的步骤,其中所述卡林林提供人真皮和表皮之间的粘附,其中所述卡林林是具有以下三个不相同链的三聚体分子: 包括BM165表位,155千道尔顿链或105千道尔顿链和140千道尔顿链的链。
-
公开(公告)号:US5580960A
公开(公告)日:1996-12-03
申请号:US141233
申请日:1993-10-22
IPC分类号: C12P21/08 , A61K38/00 , A61P17/00 , C07K14/47 , C07K14/78 , C07K16/18 , C12N5/00 , C12N5/06 , A61K38/17 , A61K38/39
CPC分类号: C12N5/0068 , C07K14/47 , C07K14/78 , C12N2533/52 , Y10S530/842 , Y10S530/851
摘要: KS-laminin and a KS-laminin-kalinin adduct are disclosed. The molecules of the invention are useful for promoting the adhesion of keratinocytes to a substrate.
摘要翻译: 公开了KS-层粘连蛋白和KS-层粘连蛋白 - 卡林林加合物。 本发明的分子可用于促进角质形成细胞与底物的粘附。
-
-
-
-
-
-
-
-
-